The identification of genetic predictors, such as HLA alleles, MICA and NKG2D SNPs, or other immune-related gene variants, may facilitate the stratification of patients with RA into subgroups based on their likelihood of responding to specific therapies. Here, MICA is linked to rheumatoid arthritis.